drugset / Trial / NCT03819647
Evaluation of the Efficacy of Stiripentol (Diacomit) as Monotherapy for the Treatment of Primary Hyperoxaluria
NaSingle-groupOpen-labelTreatment
Summary
Evaluation of the efficacy of stiripentol (Diacomit) as monotherapy for the treatment of primary hyperoxaluria. Pilot clinical study, open, prospective and multicenter.
Timeline
- Start
- 2019-05-21
- Primary completion
- 2020-12-18
- Completion
- 2021-03-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Stiripentol | Small molecule | — | Oral |